Literature DB >> 2344873

The effect of acute broncho-pulmonary infections on the FEV1 change in 13-year follow-up. The Cracow Study.

W Jedrychowski1, M Krzyzanowski.   

Abstract

The aim of this study was to assess the effect of acute bronchitis and pneumonia on the FEV1 decline rate in a random sample of Cracow inhabitants followed over a 13-year period. A total of 718 males and 1029 females completed the spirometric testing and interview in 13-year follow-up period. Acute chest diseases diagnosed and treated by doctors and reported by respondents in surveys were the source of data on broncho-pulmonary infections. The rate of FEV1 change, expressed in ml per year was estimated for each person in 13-year follow-up period. Persons who reported recurrent bronchitis and pneumonia had significantly lower initial FEV1 levels than those without infections. The effect was controlled for confounders like age, height, smoking and chronic chest symptoms. The initial low ventilatory function by itself was not a predisposing factor for chest infections, unless they were associated with chronic respiratory symptoms. Lung function in men decreased steeply after pneumonia infection, but the effect appeared to be reversible. This effect was not limited to people with pre-existing chronic respiratory disease. The data indicated that in some subjects who reported new symptoms of dyspnea on effort, the acceleration of FEV1 decline due to pneumonia was greater than in people without the symptoms. This may result from the fact that in lower respiratory infection, bacterial or viral agents can produce serious dysfunction of small airways.

Entities:  

Mesh:

Year:  1990        PMID: 2344873     DOI: 10.1007/bf00155544

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  10 in total

1.  State of the art: bronchiolitis.

Authors:  M E Wohl; V Chernick
Journal:  Am Rev Respir Dis       Date:  1978-10

2.  The natural history of chronic airflow obstruction.

Authors:  C Fletcher; R Peto
Journal:  Br Med J       Date:  1977-06-25

3.  Pneumococcus-specific immunoglobulin E in cigarette smokers.

Authors:  J W Bloom; M Halonen; A M Dunn; J L Pinnas; B Burrows
Journal:  Clin Allergy       Date:  1986-01

4.  Multivariate analysis of smoking and other risk factors for obstructive lung diseases and related symptoms.

Authors:  M D Lebowitz
Journal:  J Chronic Dis       Date:  1982

5.  Common cold with cough on the day of examination: a factor that should be taken into account in epidemiological studies on pulmonary function.

Authors:  F E Neukirch; F Kauffmann; M Korobaeff; R Liard
Journal:  Int J Epidemiol       Date:  1985-12       Impact factor: 7.196

6.  [Standard spirometric values of FVC,FEV1, FEF25-75%, FEF50-75% and FEF200-1200 estimated in random sample of healthy nonsmokers (author's transl)].

Authors:  W Jedrychowski; E Flak
Journal:  Przegl Lek       Date:  1980

7.  Acute lower respiratory illness in childhood as a predictor of lung function and chronic respiratory symptoms.

Authors:  D R Gold; I B Tager; S T Weiss; T D Tosteson; F E Speizer
Journal:  Am Rev Respir Dis       Date:  1989-10

8.  Factors associated with the change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13-year follow-up of the Cracow Study. Risk of chronic obstructive pulmonary disease.

Authors:  M Krzyzanowski; W Jedrychowski; M Wysocki
Journal:  Am Rev Respir Dis       Date:  1986-11

9.  The relation of thirteen-year mortality to ventilatory impairment and other respiratory symptoms: the Cracow Study.

Authors:  M Krzyzanowski; M Wysocki
Journal:  Int J Epidemiol       Date:  1986-03       Impact factor: 7.196

10.  The relationship of childhood respiratory illness to adult obstructive airway disease.

Authors:  B Burrows; R J Knudson; M D Lebowitz
Journal:  Am Rev Respir Dis       Date:  1977-05
  10 in total
  2 in total

Review 1.  Socioeconomic status and chronic obstructive pulmonary disease.

Authors:  E Prescott; J Vestbo
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  Plasma cathelicidin and longitudinal lung function in current and former smokers.

Authors:  Robert M Burkes; Jacquie Astemborski; Allison A Lambert; Todd T Brown; Robert A Wise; Gregory D Kirk; M Bradley Drummond
Journal:  PLoS One       Date:  2019-02-27       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.